Isthmus Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
Isthmus Partners's ACLS Position: Q3 2026 in Review
Isthmus Partners reduced its Axcelis (ACLS) stake by 20% in Q3 2026, selling an estimated $592K and leaving 18,965 shares worth $2.49M. The position accounts for 0.24% of the portfolio, ranked #104.
Isthmus Partners first reported a position in ACLS in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.73M in Q2 2024. 115 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.
- Isthmus Partners held 18,965 shares of Axcelis worth $2.49M as of Q3 2026.
- Isthmus Partners sold 4,629 Axcelis shares in Q3 2026, an estimated $592K.
- Axcelis made up 0.24% of Isthmus Partners's portfolio in Q3 2026, its #104 holding.
- Isthmus Partners first reported a position in Axcelis in Q1 2024 and has held it in 11 quarters since.
- Isthmus Partners's Axcelis position peaked at $4.73M in Q2 2024.
- 115 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.
Based on Isthmus Partners's 13F filing for Q3 2026, filed 21 Oct 2026.